Our leadership team
Thomas Senderovitz
|
ContactSend an email EducationMD from the University of Copenhagen 1992, various management and leadership courses, e.g. from the Center for Creative Leadership in the USA. Short descriptionThomas Senderovitz took over as Director General of the Danish Medicines Agency on 1 April 2016. His career includes more than 20 years working intensively with medicinal products and he has held several senior positions in international biopharmaceutical companies (Ferring Pharmaceuticals, UCB Pharma, Grünenthal GmbH). Most recently, Thomas Senderovitz was a member of the management team of the global contract research organisation PAREXEL engaging in clinical research for pharmaceutical and biotechnological companies. Thomas Senderovitz previously worked at the Clinical Pharmacological Department at Bispebjerg Hospital in Copenhagen. |
Sara Westengaard
|
ContactSend an email EducationMaster of Laws ResponsibilitiesExecutive team services, cross-functional legal and international tasks, contingency planning, communications and media relations. Short descriptionSara Westengaard joined as Director of Division of the new Directors’ Office on 1 August 2018. Sara has extensive experience with policy development, EU regulation and implementation into Danish law and with EU and international collaboration. Sara has previously worked in the Ministry of Immigration and Integration, the Ministry of Education and the Ministry of Environment and Food of Denmark. |
Iben Vitved
|
ContactSend an email EducationMSc in Economics ResponsibilitiesFinances, finance act, budgets and fee calculations, including contact with the department and the Danish national audit office. Quality Management, Cross-cutting processes and IT support. Short descriptionFor a number of years, Iben has been working with public financial management and business development. Most recently, Iben worked as chief financial officer of the Danish Security and Intelligence Service (PET) and at the IT University of Copenhagen. Iben gained her experience in the health sector when she was chief accountant of the Danish Health Authority from 2005 to 2010. |
Lars Henningsen
|
ContactSend an email EducationMA Master of Arts, History, Computer Science from Aarhus University, cand.mag. ResponsibilitiesDevelopment and execution of the IT & Digitalisation Strategy, the IT project portfolio, development tasks, supplier collaboration, information security, quality of IT systems and interactions between the IT systems of the Danish Medicines Agency and the EU as well as management of outsourced IT tasks. Short descriptionLars joined as Director of Division on 1 December 2019 with responsibility for Business IT. Lars has long experience with IT development and operation as well as digital transformation in both public and private organisations, nationally and internationally. Lars brings management experience form organisations such as the IT services company 'IT-forsyningen' and the Municipality of Copenhagen as well as the companies Siemens, IBM, Oracle and more. Lars will focus on supporting the organisation through value creation gained by technological and project-based innovation. |
Mette Aaboe Hansen
|
ContactSend an email EducationMaster of Laws ResponsibilitiesClinical trials, authorisation of human and veterinary medicinal products, compassionate use permits, product information, medicine prices and medicines law. Definition of medicinal products and illegal trading of medicinal products. Short descriptionMette Aaboe Hansen has worked as director of division at the Danish Medicines Agency since 2006 with special focus on authorisation of medicinal products, compassionate use permits and medicines law, including the related EU law, and since 2013 she has also been working with clinical trials and illegal trading of medicinal products. Before joining the pharmaceutical area, Mette worked at the Danish Veterinary and Food Administration and has experience with EU legislation, negotiation and implementation into Danish law. Over the years, Mette has also worked with issues related to medicines data, both in relation to the register of medicinal products and the exchange of data, nationally and within the EU. |
Merete Hermann
|
ContactSend an email EducationMSc in Pharmacy ResponsibilitiesInspection of companies, pharmacies, clinical trials etc. Company authorisations and import and export certificates for medicinal products and euphoriant substances. Complaints and reports of quality defects in medicinal products, including withdrawals of medicinal products. Control laboratory and standardisation work under the European Pharmacopoeia as well as publication of Danish Drug Standards. Both the inspectorate and the control laboratory hold an EN/ISO accreditation. Short descriptionMerete Hermann has been director of division at the Danish Medicines Agency since 2014 and before that she was head of unit since 2008. Merete's focus is on the quality of medicinal products through the control of medicinal products and authorisation and control of companies. Merete is an experienced manager and has worked in the private sector throughout most of her career. |
Kim Helleberg Madsen
|
ContactSend an email EducationMSc in Political Science ResponsibilitiesPharmacies, reimbursement for medicines and nutritional products as well as healthcare professionals working with industry. Short descriptionKim Helleberg Madsen has worked at the Danish Medicines Agency since 2004. He previously worked for the Danish EU representation in Brussels as a health attaché and for the European Commission with e.g. risk assessment, food legislation and biotechnology as well as for the international office of the Danish Ministry of Health. |
Nikolai Brun
|
ContactSend an email EducationMD from the University of Copenhagen 1994. Ph.D. from the University of Copenhagen with technical studies at University of Pennsylvania 1998. Various management and leadership courses. ResponsibilitiesMedical and statistical evaluation of new medicinal products. Medical and statistical evaluation in general with input to other divisions. Scientific advice procedures. Short descriptionNikolai Brun started as Director of Division of the newly formed Medical Evaluation & Biostatistics on 1 March 2017. Having trained in general medicine and pediatrics, Nikolai Brun joined the industry in 2000 and has extensive experience in drug development and medical affairs from both the pharmaceutical industry and biotech employments. He has held senior positions as head of medical teams and matrix organisations at Novo Nordisk, Genzyme and Genmab. |
Jens Piero Quartarolo
|
ContactSend an email EducationMD from the University of Copenhagen 1995, Master of Business Administration (2005) and Master of Science (2011) from Henley Business School, University of Reading, UK. ResponsibilitiesPharmacovigilance, including management and analysis of adverse reaction reports, signal generation and risk minimisation. In addition, Jens Piero Quartarolo is responsible for medical devices, including the authorisation of clinical trials involving medical devices and market surveillance. Short descriptionJens Piero Quartarolo has clinical experience from general practice as well as the areas of gynaecology and obstetrics. During the past 20 years, Jens has worked in both the Danish and the international pharmaceutical industry. His responsibilities have included medical management of areas such as clinical research, monitoring of adverse reactions, registration of medicinal products and medical information. Most recently, Jens Piero Quartarolo formed part of the European management team of the US-based company CELGENE. Previously, Jens Piero Quartarolo held executive positions in MSD, Ferring Pharmaceuticals, Organon/Schering-Plough and Abbvie. |
Jesper Kjær
|
Contact
Send an email EducationMSc in Bioinformatics, BSc (Hons) Computer Science ResponsibilitiesDevelopment and operation of the Danish Medicines Agency’s Data Analytics Center (DAC). Short descriptionJesper joined as Director of Division in the Danish Medicines Agency on 1 April 2020 with responsibility for the Data Analytics Center (DAC). Jesper brings long experience of data handing, analyses and data visualisation having worked in the academic environment and pharmaceutical industry, and he has also developed IT systems for the World Health Organization and Rigshospitalet. Jesper has also led the development of risk-based monitoring IT in Novo Nordisk and has headed activities in EU Framework Programmes, TransCelerate Biopharma and HL7. |
